An Unusual Late Presentation of Caroli Syndrome

Document Type

Conference Proceeding

Publication Date

10-25-2023

Publication Title

Am J Gastroenterol

Abstract

Introduction: Caroli syndrome is a rare autosomal recessive disorder which usually presents in early childhood. It is characterized by cystic dilation of the intrahepatic biliary tree and recurrent episodes of cholangitis with risk of progression to chronic liver disease. It is associated with the autosomal recessive polycystic kidney disease (ARPKD) gene and frequently requires endoscopic retrograde cholangiopancreatography (ERCP) for management of biliary obstruction. We present a rare case of a middle-aged man who suffered from recurrent cholangitis in setting of hepatolithiasis and was subsequently diagnosed with Caroli syndrome. Case Description/Methods: Patient is a 60-year-old male with chronic liver disease and suspected Caroli syndrome who was referred to our center for recurrent cholangitis in setting of extensive hepatolithiasis. He was initially referred to our hepatology colleagues for consideration of liver transplantation. Patient declined liver transplant evaluation and, given suspected Caroli syndrome with extensive hepatolithiasis and recurrent cholangitis, he opted to proceed with ERCP for further management. His repeat ERCP at our institution showed extensive hepatolithiasis with cystically-dilated intrahepatic bile ducts that was consistent with Caroli syndrome. Given findings, cholangioscopy with electrohydraulic lithotripsy was performed. Repeat ERCP was performed in 3 months for further stone extraction. The patient is planning to pursue serial ERCPs in an attempt to maintain biliary drainage and reduce risk of cholangitis while he considers liver transplant evaluation. Discussion: Caroli syndrome is rare and 80% of cases typically present before the age of 30. However, in a patient with chronic liver disease and cystic dilation of the intrahepatic biliary tree with hepatolithiasis and recurrent episodes of cholangitis, Caroli syndrome should be considered. Once a patient develops cirrhosis, liver transplant remains the mainstay of treatment. Biliary decompression, either via ERCP or percutaneous drainage, can be used to palliate symptoms and reduce the risk of cholangitis in patients who are either undergoing evaluation or are not candidates for liver transplantation (see Figure 1).

Volume

118

Issue

10

First Page

S1538

Last Page

S1539

Share

COinS